U.S. Stock Night Market Opening Movements
Zynex fell 9.43% in the night market, with no significant news recently. Trading was active, and capital flow was evident. Considering the sector and industry trends, the stock showed significant volatility, and the specific reasons need further observation.
Banco Santander SA-Spon rose 7.77% in the night market. Based on recent key news:
<ol>
<li>
On November 27, Morgan Stanley analysts raised the target price for Banco Santander SA-Spon to €11, anticipating net interest income and loan growth in the Eurozone. The analysts' optimistic outlook for Banco Santander SA-Spon drove the stock price up.
</li>
<li>
On November 27, the European Central Bank advised Banco Santander SA-Spon to increase liquidity and capital buffers to address concerns over dollar exposure and currency volatility. This move enhanced market confidence in Banco Santander SA-Spon's financial stability, promoting the stock price rise.
</li>
<li>
On November 26, Banco Santander SA-Spon participated in providing a £275 million revolving credit facility, extending the debt maturity of Harworth Group PLC by about 2.5 years. This move demonstrated Banco Santander SA-Spon's active performance in the credit market, further supporting the stock price increase. The expectation of loan growth in the Eurozone boosted market confidence.
</li>
</ol>
Top Gainers in the U.S. Stock Night Market
HeartBeam rose 44.77% in the night market. Based on recent key news:
<ol>
<li>
On November 26, HeartBeam updated the regulatory pathway for its 12-lead electrocardiogram synthesis software application. This update was released following the FDA's decision, showing the company's progress in technology and product development, driving the stock price up.
</li>
<li>
On November 26, HeartBeam released usage instructions for its portable non-invasive electrocardiogram recorder. The device is designed to record, store, and transmit patients' three-lead electrocardiograms, suitable for clinical or home environments. The market potential of this product is viewed positively by investors, further stimulating the stock price rise.
</li>
<li>
On November 26, HeartBeam published original content via Business Wire, emphasizing its transparency and accountability in information release, enhancing market confidence. The medical device industry has performed strongly recently, with evident capital inflow.
</li>
</ol>
TMC rose 18.70% in the night market. Based on recent key news:
<ol>
<li>
On November 27, TMC The Metals Company may solve the global metal shortage issue, and if regulatory approval is obtained, the stock price will rise significantly. This news drove the stock price up by 18.70%.
</li>
<li>
On November 25, Washington's increased interest in critical mineral supplies is favorable for TMC's innovative mining business, further supporting the stock price rise.
</li>
<li>
On November 28, analysts rated TMC as a hold. Although it was not listed among the top five recommended buy stocks, market attention to its long-cycle seabed strategy has increased. The demand for critical minerals is rising, and market focus is high
Reynolds rose 17.70% in after-hours trading, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation
</li>
</ol>

ZYXI

Zynex fell 9.43% in after-hours trading; Banco Santander SA-Spon rose 7.77% in after-hours trading; HeartBeam rose 44.77% in after-hours trading; TMC the Metals rose 18.70% in after-hours trading; Reynolds rose 17.70% in after-hours trading

U.S. stock night trading opens with fluctuations: Zynex drops 9.43% in night trading; Banco Santander SA-Spon rises 7.77% in night trading